SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is currently experiencing extreme volatility and intense community debate surrounding a scheduled reverse stock split. Investors remain deeply divided, with many expressing frustration over long-term price declines and management performance, while a vocal group of traders speculates on a potential short squeeze or value recovery.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund (VCX) is experiencing significant volatility and aggressive upside momentum as retail traders speculate on the valuation of its underlying private tech holdings, including Anthropic, SpaceX, and OpenAI. The community is heavily focused on the restricted nature of the floatwith many early shareholders under a six-month lockupleading to intense debate between those anticipating a continued squeeze and skeptics warning that the current trading price represents an unsustainable premium to the fund's net asset value.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is experiencing intense speculation as a trending meme coin, sparking polarized debate between participants chasing rapid gains and those dismissing it as a high-risk pump-and-dump scheme. The community remains divided, with some actively trading based on volatility while others express skepticism regarding its legitimacy and high concentration of ownership.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Investors are actively weighing the impact of Assertios recent clinical data on same-day Rolvedon dosing against persistent concerns over the company's valuation, legal overhang, and potential reverse stock split. While the stock continues to trade below its net cash per share, community sentiment remains split between those accumulating shares as a deep-value turnaround play and those frustrated by the lack of immediate price appreciation and management's conservative strategic approach.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is currently at the center of investor attention following the early release of its record financial results and a raised 2026 revenue guidance, alongside the strategic acquisition of World View. The community is actively debating the company's aggressive roll-up strategy and the potential for a breakout, with many investors weighing the significant growth potential against concerns over dilution and cash burn ahead of the upcoming earnings call.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is currently trending due to intensifying market rumors and unconfirmed reports regarding a potential acquisition by a large U.S.-based biopharmaceutical company. Investors are actively discussing the stock's M&A potential alongside its long-term growth prospects, specifically the performance of its lead HAE drug and the development of its pipeline assets.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines shares are experiencing significant volatility as investors weigh the company's ambitious growth guidance and long-term infrastructure potential against earnings results. The community is sharply divided, with bulls pointing to a massive revenue outlook and impending lunar contract awards, while bears remain focused on valuation concerns and the high execution risks inherent in the space sector.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in George Town, Cayman Islands.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is facing volatility driven by political uncertainty in Brazil surrounding the 2026 election cycle and broader regional economic concerns. Despite the recent price drop, the community remains heavily focused on the company's long-term growth story, actively debating the sustainability of its digital banking expansion and the potential for a U.S. market entry.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is actively trading on heightened investor interest as the company nears its earnings release, with discussions focused on its strategic role in domestic magnet production, significant U.S. government funding, and its pivot to supply critical components for the defense and automotive sectors. Community sentiment remains fixated on the company's ability to capitalize on reduced reliance on foreign rare earth supply chains, while traders closely monitor its technical positioning against potential short-squeeze catalysts and volatility surrounding ongoing geopolitical mineral trade tensions.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is currently seeing heightened volatility and intense community debate following a shelf offering announcement, which has sparked fears among some investors regarding financial strain while others view it as a potential strategic move. Market participants are closely watching critical support and resistance levels as the stock remains range-bound, with community sentiment deeply divided between those calling for a further breakdown and long-term investors advocating for accumulation ahead of anticipated April regulatory catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biofrontera (BFRI) Q4 2025 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Are Medical Stocks Lagging  Align Technology (ALGN) This Year?

Here is how Align Technology (ALGN) and Biofrontera Inc. (BFRI) have performed compared to their sector so far this year.

Biofrontera Inc. (BFRI) Upgraded to Buy: Here's Why

Biofrontera Inc. (BFRI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Biofrontera Inc. (BFRI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Biofrontera Inc. (BFRI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Is Biofrontera Inc. (BFRI) Stock Outpacing Its Medical Peers This Year?

Here is how Biofrontera Inc. (BFRI) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.

Biofrontera Earnings Preview

Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Lags Revenue Estimates

Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of -3.70% and -75.13%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates

Lifecore Biomedical (LFCR) delivered earnings and revenue surprises of +3.33% and +16.60%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?

Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates

Viridian Therapeutics (VRDN) delivered earnings and revenue surprises of +58.54% and +50.85%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

PTC Therapeutics (PTCT) Q3 Earnings and Revenues Top Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of +116.81% and +20.17%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company focuses on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.

BFRI
Biofrontera Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BFRI News

BFRIBiofrontera Inc